Abstract:In the vanguard of oncological advancement, this investigation delineates the integration of deep learning paradigms to refine the screening process for Anticancer Peptides (ACPs), epitomizing a new frontier in broad-spectrum oncolytic therapeutics renowned for their targeted antitumor efficacy and specificity. Conventional methodologies for ACP identification are marred by prohibitive time and financial exigencies, representing a formidable impediment to the evolution of precision oncology. In response, our research heralds the development of a groundbreaking screening apparatus that marries Natural Language Processing (NLP) with the Pseudo Amino Acid Composition (PseAAC) technique, thereby inaugurating a comprehensive ACP compendium for the extraction of quintessential primary and secondary structural attributes. This innovative methodological approach is augmented by an optimized BERT model, meticulously calibrated for ACP detection, which conspicuously surpasses existing BERT variants and traditional machine learning algorithms in both accuracy and selectivity. Subjected to rigorous validation via five-fold cross-validation and external assessment, our model exhibited exemplary performance, boasting an average Area Under the Curve (AUC) of 0.9726 and an F1 score of 0.9385, with external validation further affirming its prowess (AUC of 0.9848 and F1 of 0.9371). These findings vividly underscore the method's unparalleled efficacy and prospective utility in the precise identification and prognostication of ACPs, significantly ameliorating the financial and temporal burdens traditionally associated with ACP research and development. Ergo, this pioneering screening paradigm promises to catalyze the discovery and clinical application of ACPs, constituting a seminal stride towards the realization of more efficacious and economically viable precision oncology interventions.

ME-ACP: Multi-view Neural Networks with Ensemble Model for Identification of Anticancer Peptides

EnACP: an Ensemble Learning Model for Identification of Anticancer Peptides

ACPNet: A Deep Learning Network to Identify Anticancer Peptides by Hybrid Sequence Information

Prediction of anticancer peptides based on an ensemble model of deep learning and machine learning using ordinal positional encoding

DeepACP: A Novel Computational Approach for Accurate Identification of Anticancer Peptides by Deep Learning Algorithm

ACP-ML: A sequence-based method for anticancer peptide prediction

iACP-DFSRA: Identification of Anticancer Peptides Based on a Dual-channel Fusion Strategy of ResCNN and Attention

ACP-DL: A Deep Learning Long Short-Term Memory Model to Predict Anticancer Peptides Using High-Efficiency Feature Representation

Integrating Traditional Machine Learning and Deep Learning for Precision Screening of Anticancer Peptides: A Novel Approach for Efficient Drug Discovery

MA‐PEP: A novel anticancer peptide prediction framework with multimodal feature fusion based on attention mechanism

Efficient Screening of Pharmacological Broad-Spectrum Anti-Cancer Peptides Utilizing Advanced Bidirectional Encoder Representation from Transformers Strategy

Integrating Multiple Sequence Features for Identifying Anticancer Peptides

Anticancer Peptide Prediction <i>via</i> Multi-Kernel CNN and Attention Model

Active Semisupervised Model for Improving the Identification of Anticancer Peptides.

DLFF-ACP: prediction of ACPs based on deep learning and multi-view features fusion

Effective identification and differential analysis of anticancer peptides

ACP-check: An anticancer peptide prediction model based on bidirectional long short-term memory and multi-features fusion strategy

Anticancer peptides prediction with deep representation learning features

ACP-MLC: A two-level prediction engine for identification of anticancer peptides and multi-label classification of their functional types

ANNprob-ACPs: A novel anticancer peptide identifier based on probabilistic feature fusion approach

Anti-Cancer Peptides Identification and Activity Type Classification with Protein Sequence Pre-training